TY - JOUR
T1 - Phenotypic expansion of KMT2D-related disorder
T2 - Beyond Kabuki syndrome
AU - Baldridge, Dustin
AU - Spillmann, Rebecca C.
AU - Wegner, Daniel J.
AU - Wambach, Jennifer A.
AU - White, Frances V.
AU - Sisco, Kathleen
AU - Toler, Tomi L.
AU - Dickson, Patricia I.
AU - Cole, F. Sessions
AU - Shashi, Vandana
AU - Grange, Dorothy K.
N1 - Funding Information:
We are grateful to the patients and their families for participating in this publication. We acknowledge Alexander Paul for his expert exome sequence analysis. We appreciate the helpful comments provided by the reviewers of this manuscript. Research reported in this manuscript was supported by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director under Award Number U01HG010215 (FSC, JAW, DB), by the National Heart, Lung, and Blood Institute under Award Number K12HL120002 (DB), and by the National Human Genome Research Institute under Award Number K08HG010154 (DB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding for this project was provided by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital (FSC, JAW). Patient 3 in this publication was enrolled in Protocol #32301: Genomic Study of Medical, Developmental, or Congenital Problems of Unknown Etiology, which was supported by the Duke University Health system and partially funded by UCB Celltech (VS).
Publisher Copyright:
© 2020 Wiley Periodicals, Inc.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Pathogenic variants in KMT2D, which encodes lysine specific methyltransferase 2D, cause autosomal dominant Kabuki syndrome, associated with distinctive dysmorphic features including arched eyebrows, long palpebral fissures with eversion of the lower lid, large protuberant ears, and fetal finger pads. Most disease-causing variants identified to date are putative loss-of-function alleles, although 15–20% of cases are attributed to missense variants. We describe here four patients (including one previously published patient) with de novo KMT2D missense variants and with shared but unusual clinical findings not typically seen in Kabuki syndrome, including athelia (absent nipples), choanal atresia, hypoparathyroidism, delayed or absent pubertal development, and extreme short stature. These individuals also lack the typical dysmorphic facial features found in Kabuki syndrome. Two of the four patients had severe interstitial lung disease. All of these variants cluster within a 40-amino-acid region of the protein that is located just N-terminal of an annotated coiled coil domain. These findings significantly expand the phenotypic spectrum of features associated with variants in KMT2D beyond those seen in Kabuki syndrome and suggest a possible new underlying disease mechanism for these patients.
AB - Pathogenic variants in KMT2D, which encodes lysine specific methyltransferase 2D, cause autosomal dominant Kabuki syndrome, associated with distinctive dysmorphic features including arched eyebrows, long palpebral fissures with eversion of the lower lid, large protuberant ears, and fetal finger pads. Most disease-causing variants identified to date are putative loss-of-function alleles, although 15–20% of cases are attributed to missense variants. We describe here four patients (including one previously published patient) with de novo KMT2D missense variants and with shared but unusual clinical findings not typically seen in Kabuki syndrome, including athelia (absent nipples), choanal atresia, hypoparathyroidism, delayed or absent pubertal development, and extreme short stature. These individuals also lack the typical dysmorphic facial features found in Kabuki syndrome. Two of the four patients had severe interstitial lung disease. All of these variants cluster within a 40-amino-acid region of the protein that is located just N-terminal of an annotated coiled coil domain. These findings significantly expand the phenotypic spectrum of features associated with variants in KMT2D beyond those seen in Kabuki syndrome and suggest a possible new underlying disease mechanism for these patients.
KW - KMT2D
KW - Kabuki syndrome
KW - athelia
UR - http://www.scopus.com/inward/record.url?scp=85083907753&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.61518
DO - 10.1002/ajmg.a.61518
M3 - Article
C2 - 32083401
AN - SCOPUS:85083907753
SN - 1552-4825
VL - 182
SP - 1053
EP - 1065
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 5
ER -